MedPath

Immune activity by radiofrequency ablation (RFA) in non-resected biliary tract cancer

Not Applicable
Recruiting
Conditions
Biliary tract cancer
Biliary Tract Neoplasm, Biliary Tract Cancer
D001661
Registration Number
JPRN-jRCT1050230099
Lead Sponsor
Kitano Masayuki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients with biliary tract cancer with obstructive jaundice
Patients who need endoscopic biliary drainage and are scheduled for stenting
Patients over 20 years old
Patients with unresectable biliary tract cancer
Patients with performance status 2 or lower

Exclusion Criteria

Patients with bleeding tendency
Patients with difficulty in endoscopic insertion
Patients with difficulty in endoscopic biliary drainage
Patients who are unable to give consent.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath